4//SEC Filing
AUXILIUM PHARMACEUTICALS INC 4
Accession 0001209191-14-070838
CIK 0001182129operating
Filed
Nov 23, 7:00 PM ET
Accepted
Nov 24, 4:59 PM ET
Size
21.3 KB
Accession
0001209191-14-070838
Insider Transaction Report
Form 4
WILLS ALAN
EVP, Corporate Development
Transactions
- Sale
Common Stock
2014-11-20$33.18/sh−13,717$455,086→ 30,743 total - Exercise/Conversion
Nonqualified Stock Option (Right to Buy)
2014-11-20−9,375→ 28,125 totalExercise: $18.30From: 2014-02-07Exp: 2023-02-07→ Common Stock (9,375 underlying) - Exercise/Conversion
Common Stock
2014-11-20$19.51/sh+28,500$556,035→ 177,960 total - Exercise/Conversion
Nonqualified Stock Option (Right to Buy)
2014-11-20−75,000→ 0 totalExercise: $25.90From: 2011-10-25Exp: 2020-10-25→ Common Stock (75,000 underlying) - Exercise/Conversion
Nonqualified Stock Option (Right to Buy)
2014-11-20−30,000→ 10,000 totalExercise: $22.04From: 2012-02-17Exp: 2021-02-17→ Common Stock (30,000 underlying) - Exercise/Conversion
Nonqualified Stock Option (Right to Buy)
2014-11-20−28,500→ 28,500 totalExercise: $19.51From: 2013-02-14Exp: 2022-02-13→ Common Stock (28,500 underlying) - Exercise/Conversion
Common Stock
2014-11-20$25.90/sh+75,000$1,942,500→ 119,460 total - Exercise/Conversion
Common Stock
2014-11-20$22.04/sh+30,000$661,200→ 149,460 total - Exercise/Conversion
Common Stock
2014-11-20$18.30/sh+9,375$171,563→ 187,335 total - Sale
Common Stock
2014-11-20$33.18/sh−142,875$4,740,207→ 44,460 total
Footnotes (1)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.10 to $33.36, inclusive.
Documents
Issuer
AUXILIUM PHARMACEUTICALS INC
CIK 0001182129
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001182129
Filing Metadata
- Form type
- 4
- Filed
- Nov 23, 7:00 PM ET
- Accepted
- Nov 24, 4:59 PM ET
- Size
- 21.3 KB